J&J pauses vaccine trial
Participant falls ill
Johnson & Johnson (US:JNJ) has suspended its clinical trials for a Covid-19 vaccine, after a study participant fell ill. The company said that the person will be reviewed and evaluated by an independent board, as well as internal clinical and safety physicians. It has suspended recruitment to the Phase III trial as a precaution, although noted that with a trial so large it was not unusual for someone to become unwell. Last month UK group AstraZeneca (AZN) paused its trial after one participant developed an unexplained illness.
Apple’s new iPhone
5G enabled